Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Preston Mason

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Journal of Cardiovascular Pharmacology|August 8, 2006
Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activityR Preston Mason, Ruslan Kubant, Robert F Jacob, et al.
BMC Pharmacology & Toxicology|October 1, 2013
The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cellsR Preston Mason, Robert F Jacob, J Jose Corbalan, et al.
Current Atherosclerosis Reports|December 29, 2022
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate ContinuesSamuel C R Sherratt, Peter Libby, Matthew J Budoff, et al.
Cardiovascular Research|January 22, 2024
Do patients benefit from omega-3 fatty acids?Samuel C R Sherratt, R Preston Mason, Peter Libby, et al.
Investigative Ophthalmology & Visual Science|October 17, 2013
1,2-naphthoquinone stimulates lipid peroxidation and cholesterol domain formation in model membranesRobert F Jacob, Michael D Aleo, Yehudi Self-Medlin, et al.
Atherosclerosis|November 9, 2004
Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDsMary F Walter, Robert F Jacob, Charles A Day, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 7, 2023
Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollutionSamuel C R Sherratt, Peter Libby, Hazem Dawoud, et al.
Journal of Lipid Research|August 17, 2021
EPA and DHA containing phospholipids have contrasting effects on membrane structureSamuel C R Sherratt, Rebecca A Juliano, Christina Copland, et al.
British Journal of Clinical Pharmacology|January 31, 2012
Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variantsR Preston Mason, Robert F Jacob, Ruslan Kubant, et al.
Journal of Cardiovascular Pharmacology|February 22, 2008
Effect of beta-blockers on endothelial function during biological aging: a nanotechnological approachPhilip Funovic, Mykhaylo Korda, Ruslan Kubant, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Journal of Cardiovascular Pharmacology|August 8, 2006
Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activityR Preston Mason, Ruslan Kubant, Robert F Jacob, et al.
BMC Pharmacology & Toxicology|October 1, 2013
The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cellsR Preston Mason, Robert F Jacob, J Jose Corbalan, et al.
Current Atherosclerosis Reports|December 29, 2022
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate ContinuesSamuel C R Sherratt, Peter Libby, Matthew J Budoff, et al.
Cardiovascular Research|January 22, 2024
Do patients benefit from omega-3 fatty acids?Samuel C R Sherratt, R Preston Mason, Peter Libby, et al.
Investigative Ophthalmology & Visual Science|October 17, 2013
1,2-naphthoquinone stimulates lipid peroxidation and cholesterol domain formation in model membranesRobert F Jacob, Michael D Aleo, Yehudi Self-Medlin, et al.
Atherosclerosis|November 9, 2004
Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDsMary F Walter, Robert F Jacob, Charles A Day, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 7, 2023
Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollutionSamuel C R Sherratt, Peter Libby, Hazem Dawoud, et al.
Journal of Lipid Research|August 17, 2021
EPA and DHA containing phospholipids have contrasting effects on membrane structureSamuel C R Sherratt, Rebecca A Juliano, Christina Copland, et al.
British Journal of Clinical Pharmacology|January 31, 2012
Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variantsR Preston Mason, Robert F Jacob, Ruslan Kubant, et al.
Journal of Cardiovascular Pharmacology|February 22, 2008
Effect of beta-blockers on endothelial function during biological aging: a nanotechnological approachPhilip Funovic, Mykhaylo Korda, Ruslan Kubant, et al.
Pageof 10